Topics

Public Workshop: FDA/FTC Workshop on a Competitive Marketplace for Biosimilars - 03/09/2020 - 03/09/2020

06:32 EST 3 Feb 2020 | FDA

The purpose of the public workshop is to discuss FDA and FTC’s collaborative efforts to support appropriate adoption of biosimilars, discourage false or misleading statements about biosimilars, and deter anticompetitive behaviors in the biologic marketplace.

Original Article: Public Workshop: FDA/FTC Workshop on a Competitive Marketplace for Biosimilars - 03/09/2020 - 03/09/2020

NEXT ARTICLE

More From BioPortfolio on "Public Workshop: FDA/FTC Workshop on a Competitive Marketplace for Biosimilars - 03/09/2020 - 03/09/2020"

Quick Search

Relevant Topic

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...